BCRX
BioCryst Pharmaceuticals Inc
Mentions (24Hr)
0.00% Today
Reddit Posts
BCRX stock at nine-month low as Q4 bottom-line disappoints (NASDAQ:BCRX)
My bot picked these for the week 2023-1-23 ;)
$BCRX POS-045 Evaluating BCX9930, an Oral Factor D Inhibitor A Proof-of-Concept Study (RENEW) Data Gathering
$BCRX YOLO long term yolo 660 shares still adding!
A buyout is brewing at BioCryst (BCRX) NOW
A buyout is brewing at BioCryst (BCRX) Right Now
A year ago I shared how 5 minutes in the future led me to pick $BCRX and it became one of my top posts of all time. After this week, I don't look quite so crazy.
I Yolo’ed BCRX a while back… i ain’t folding till it’s triple digits. Lookin to squeeze tomorrow.
BCRX Who needs portfolio diversity? YOLO Gain Porn!
BioCryst (BCRX) YOLO! Let’s go!!! 🚀 🚀🚀
$BCRX undervalued; trading at $13 but based on competitors DD should be trading at $56 - up 10% on last Friday
$BCRX DD, the perfect entry point 🌝 🚀
$BCRX BioCryst scraps $200M offering after seeing share price slide. #BioWar 🚀🚀🚀
$BCRX Withdraws Public Offering
How wants to see a bear roast?
BCRX Q2 Earnings Play August 5th - $187k YOLO 🧪🔬👩🔬👨🔬🚀
Riding BCRX through Q2 and beyond - $171k YOLO
BCRX DD - Potentially the best Bio-Investment
HELP! Bull Put Spread on IBKR mobile - may have done it wrongly!!
$BCRX - Update on wife's Roth started last fall with ~$17,000 @ $75,000 investing in $BCRX - Gain Porn
$BCRX Fundamentally sound with the potential for a short squeeze. Join me fellow apes.
If at all there comes a time for BioWar, I think $BCRX will be leading the way.
BCRX huge upside for a long hold. Insiders increasing position sizes.
BCRX DD - Potentially the best Risk/Reward Investment in the Bio-sector. 10x bagger for the upcoming 5 years.
INO made nice gains today with significant uptick in volume. Also taking notice in WSB
A bargain to buy BCRX at 17$ : should be soon at 100$. Very undervalued. I’m buying
What is everyone BUYING??? ...current portfolio SPCE, AMC, BB, VBIV, BCRX, GPRO, APYP, FCEL, CETY, IPNFF, DS, BRTX, ZOM, many more🚀🌖
$bcrx - Wife’s account update | Took wife’s Roth from 15k in September to 63k today Investing in $BCRX (gain porn)
Anybody has position on BCRX is a gold-mine holder💎💎
Well, I guess its time to move on from GME & AMC
Main Reasons why I would INVEST in $BCRX before Q2 ER
BCRX killed it! Get in now while you can afford it.
Biocryst Pharme !! $BCRX embarrassed of riches!! DD 🚀🚀🚀🚀🚀
Has anyone seen biocryst pharma ? It’s $11 and should be 200 BCRX
$BCRX Big Pharma Assassin BCX9930 to Jump from Phase 1 to Phase 3 Pivotal Trials in PNH
Biocryst ($BCRX) continues to remain undervalued
$BCRX Big Pharma Assassin BCX9930 to Jump from Phase 1 to Phase 3 Pivotal Trials in PNH
$BCRX Big Pharma Assassin BCX9930 to Jump from Phase 1 to Phase 3 Pivotal Trials in PNH
$BCRX (Biocryst)’s Factor D inhibitor BCX9930 hit it out of the park on R&D day!
Revival of a company Wall St. believed to be a zombie - Cathies' Takeda about to get burned? - BCRX investor and activist investor dreams becoming realized!
Fuck RBC, CITADEL, MELVIN AND EVERYONE SHORTING BCRX
BCRX - JPM on the trial results Monday
🦍Monday Monday Monday, 🤟🏼$BCRX🤟🏼we taking this shit to the moon 🌝🚀💰💰☃️☃️☃️☃️☃️☃️☃️🦍
Mentions
BCRX: I posted this last night. There recent earnings were really good and November earnings expected to be good as well. Currently at 6.76. PT between 18-24. Recent acquisition. Good buy and hold through November earnings. https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bcrx/biocryst-pharmaceuticals/news/biocryst-pharmaceuticals-bcrx-exploring-valuation-following?utm_medium=article&utm_source=robinhood BCTX: Also has promising phase 3 results coming out soon. Stock is at 11.72. Was at 50.00 in April.. Check out the recent news and encouraging PT.
I like both but for mid plays not to daytrade or for a few days. I like both long too. I really like BCRX as a buy and hold through earnings in November.
BCRX..buy and hold through earnings in November or until run up. BCTX..in April it was at 50.00
BCRX: Very interesting! Currently 6.79 First article PT raised from 24 to 26 https://www.tipranks.com/news/the-fly/biocryst-price-target-raised-to-26-from-24-at-cantor-fitzgerald-thefly?utm_source=robinhood.com&utm_medium=referral Recent acquisition https://www.tipranks.com/news/ratings/biocrysts-strategic-acquisition-of-astria-therapeutics-enhancing-hae-portfolio-with-navenibart-ratings?utm_source=robinhood.com&utm_medium=referral Last earnings were excellent Early November earnings are projected to be really good. This could be a great buy and hold for a few weeks!!!! BCTX: Also interesting. Phase 3 results upcoming catalyst https://www.gurufocus.com/news/3140160/briacell-bctx-to-present-key-phase-3-study-data-at-esmo-congress-2025 PT 40.00 https://www.investing.com/news/analyst-ratings/hc-wainwright-reiterates-buy-rating-on-briacell-stock-ahead-of-phase-3-data-93CH-4285693
BCRX just aquired ATXS BCRX has 27.5M shares shorted. Could be ugly
So is nobody buying $BCRX right now??? WE REALLY NEED BIOWAR TO PICK UP AGAIN!!!
I think it’s time $BCRX gets some retail help. Unbelievably undervalued. #BioWar2.0
Hold BCRX because I'm too scared to sell
Love SRRK and BCRX for short-to-medium term. Both have had great clinical results and are extremely undervalued relative to other stocks close to approval. BCRX by the way PDUFA is in December now, but fantastic time to start loading up.
I'm still yolo on BCRX
I’ve sold mine for a nice profit Focused on BCRX right now
MVST has earnings in the morning. Last earnings did an increase of 100%. BCRX has earnings tomorrow so keep an eye. AUUDW could cross 4. BTCS could have a pump due to Bitcoin. Was 8 few months ago. NCNA have a reverse split finalising on Monday. They could announce a merger on pre market which would put crazy amount of buying after market opens. Currently halted. NYXOAH - FDA Approval Today. Could rocket at open. MBOT - Waiting for approval, could rocket CTM - Posted Good Earnings
7% approval Dems trail 🥭, 🍈 party, and Mamdani. Yet have absurdly outsized influence & control over Reddit. Blah, blah, blah, something about democracy. Calls on BCRX (cause you missed MP)
7% approval Dems too busy trying to gaslight America into believing the shelves are bare...like Sleepy Joe Autopen was fit as a fiddle...to buy MP over months 🦅 Oh, here's a lil' violin 🎻 Calls on BCRX
7% approval rating DNC bots on here en force, per usual. Butthurt Mamdani rekt their legacy play for NYC Mayor. Calls on BCRX (like MP...which was ONLY ticker I suggested over last several weeks...and 🚀)
I think by now last week, I sadly, topped the entire weekend comment count shit posting here during lame Friday. But often said "calls on MP" many times. Ya see what happened? Jumped 50% other day. Feel free to check my comments. (Please don't, that's pathetic. But, they are there.) Sold at open Thursday when popped, for $44.54, at average cost $22.80 (after holding about 3mo) The 7% approval rating Democrats hate bagging fries. Calls on BCRX 🥳
That's a good one. 1 of 2 only healthcare own (other is BCRX)
I, the old millennial I am, AGAIN, elected to not play any options and just added a little to my individual stock account that's up 23% YTD (obvi my money is tied in it tho) TTD & BCRX are f'n rad. Legit, I just have. They're great. Try just pocketing a lil' at shares kids 👴
Sold all my MRVL bought BCRX
Hey, I stumbled my way here, too. I have been selling covered calls lately and have been analyzing how it would play out if I added 2 year leaps at the same strike price that I am selling the monthlies. I haven't simulated it yet, but my theory is that the stock price will stay below my strike until a catalyst, and if/when it breaks out, I will have upside exposure. The 2 year leap is about 1/6 the price of the covered calls, so I still get my income from them. I have a question for you since you said you trade uranium. What do you think of DNN? Their ratios are good. They have a good outlook for Wheeler River, and mining is supposed to resume this year at McClean Lake. They are also sitting on a bunch of uranium. My concerns are revenue and, of course, the risks involved with investing in uranium. They are also a small company, but I like them like that sometimes. I trade BCRX, and studying DNN feels like a uranium version of them.
WHERES BCRX 
i just wanna see if BCRX goes on the board
Ban bet BCRX to $11 next week
Hoping BCRX shows some promising earnings
lets go BCRX 
$BCRX and $NABL ER next week 
$BCRX and $NABL ER next week 
$BCRX $NABL earnings and $LUNR launch, the 24th - 28th is gonna be a big few days for my portfolio
#**TLDR** --- **Ticker:** NVAX, VCEL, MRK, PFE, BCRX **Direction:** Up **Prognosis:** Bird flu getting serious, buy pharma stonks. Also, buy cat hazmat suits. **Catalyst:** H5N1 D1.1 genotype with mutations similar to 1918 Spanish Flu, potential for increased human pathogenicity. Cases popping up along the Pacific and Mississippi flyways, impacting ~100 million people. Cats are getting it too now.
$KALA $BCRX $CKPT any there’s many more depending on risk / reward
You hear me?!? It’s all about BCRX.
$BCRX has earrnings Monday before market.. I have $6 puts ..anyone playing this next week?
There are a lot to choose from. CVAC BCRX DYAI NNVC LAKE. The question is which ones will go up the most
BCRX had a monster rally last time
Look to buy $BCRX if this avian flu becomes a thing.
BCRX and VTNR are the wildest ones I've come across.
BCRX
Ghey earnings this week. My lotto tickets picks ELAN and BCRX both missed.
Ugh, was going to short BCRX and got scared. Oh well.
Anyone know anything about BCRX? Want to short based on chart but I'm biostocks always have violent jumps.
Good luck on trying any... I don't really have a great success rate with trying to play this type of stuff so not recommending copying me. I have only really made big money on the following: Caught the GME squeeze in 2021 and got out. Puts on AMC when the reverse split happened. Long-term holding TSLA, AMZN, GOOG. Fortunately those have offset losses on things like BCRX which I lost a ton on, PLTR which I bought at the high and lost on, QS which I also bought early on and lost... oh, and when AMC squeezed originally, I bought puts and shorted which ended poorly (with puts on AMC when the reverse split happened, I am overall nicely up on that but it was a painful loss when my initial plays there went wrong).
I still have a paper money account from when I started practicing. The two best stocks I have there are NVDA at 11.64 and TSLA at 3.03. Both up 6K% 🤣 in real life, best investment currently is NU. I found out about them through a friend of mine, and my return in that stock is over 100% (more if you take into account all the call options i owned as well). I’m still holding the stock and bought more LEAPs (all of which are also up more than 50%). Before this one was BCRX, I found them while doing a screener and liked the company’s pipeline. Bought at 3 sold at 9 never went back in
Biocryst Pharmaceuticals Inc Current valuation overly discounts Orladeyo; Upgrade to Buy Rating Change: BUY | PO: 10.00 USD | Price: 7.19 USD Recent stock pull-back offers attractive buying oppy Biocryst Pharmaceuticals (BCRX) is commercial stage company focused on developing oral medicines for rare diseases. BCRX’s lead asset Orladeyo is approved as a prophylactic (preventative) treatment for hereditary angioedema (HAE), which is a rare genetic disease characterized by rapid, uncontrolled swelling of body tissues. Current HAE treatment is classified as either acute or prophylactic with several approved treatment options on the market. In 2020, Orladeyo entered this market as the first and only oral prophylactic therapy for HAE. We note recent pullback in shares (based on no fundamental change) now presents meaningful upside potential to our $10 PO. We model $78mn in 2Q sales and model $320mn in FY23 sales, which we think is achievable. BCRX guidance is for sales of at least $320mn in 2023. Given our view that our $629mn peak sales estimate does not require outsized future growth, we raise our rating for BCRX shares to Buy from Neutral. Mgmt anticipates $1bn in peak Orladeyo sales We estimate Orladeyo 2Q sales of $78mn. Mgmt continues to highlight the strong launch, reporting >1k pts on therapy. As such, we continue to view the Orladeyo launch positively though we note mgmt’s comments about peak sales of $1bn still need additional validation from sales trends in the coming years. We also think achievement of such sales still needs additional physician support (KOL feedback noting pt hesitancy on switching from current prophylaxis injectables), 60% first-year retention rate for Orla’ and increased competition as newer therapies could enter the space (e.g. PHVS, NTLA). ‘10013 clinical program delay remains ongoing On pipeline, BCX10013 (an oral complement inhibitor) remains on clinical delay due to dose-related nonclinical observations with preclinical dose-related toxicology studies on- track to complete by YE. On the 2Q earnings call, we look for updates on the extent of the clinical delay as well as company guidance on next steps for the program. Changes to our DCF-based model We roll the qtr and adjust op-ex to be in-line with trend. We note Orladeyo is the sole driver to our valuation contributing $12/sh (offset by negative NPV for pipeline spend). Risks to our thesis are higher than expected dropout rate and stronger competition. 13 July 2023 Equity Key Changes ( US$) Tazeen Ahmad Research Analyst
Anyone in $BCRX price action looking tempting
I got legit Bogdanoffed on BCRX. 
I added 500 shares of BCRX on Friday.
My buys: 23-01-2023 19:29:33; AXSM 68.05000305175781,0 buy 23-01-2023 19:40:27; BCRX 10.010000228881836,0 already in 23-01-2023 19:42:25; BCC 67.9000015258789,0 sold n bought 23-1 signal 23-01-2023 19:54:49; WEN 22.170000076293945,0 buy 23-01-2023 19:59:50; REG 63.459999084472656,0 buy (broker wanted a REIT exam for this wich GPT went through easy)
My buys for the week: 23-01-2023 19:29:33; AXSM 68.05000305175781,0 buy 23-01-2023 19:40:27; BCRX 10.010000228881836,0 already in 23-01-2023 19:42:25; BCC 67.9000015258789,0 sold n bought 23-1 signal 23-01-2023 19:54:49; WEN 22.170000076293945,0 buy 23-01-2023 19:59:50; REG 63.459999084472656,0 buy (broker wanted a REIT exam for this wich GPT went through easy)
>You're a fucking idiot if you think buying AXSM, BCRX, and BCC is going to make you money. I wouldn't touch those stocks with a 10 foot pole. WEN might be ok but REG is garbage.
Anyone thinking of playing BCRX with this Ebola shit played well like 7-8 years ago with that random surge
They've just corrupted the DNA of millions and you dare demand immediate proof lol you know nothing about cancer, how it arises, how it spreads, what causes it's creation but here ya go buddy! [https://www.mdpi.com/1467-3045/44/3/73](https://www.mdpi.com/1467-3045/44/3/73) [https://www.haaretz.com/israel-news/2022-07-27/ty-article-magazine/.premium/crispr-technology-for-dna-editing-might-raise-cancer-risk-israeli-scientists-say/00000182-3ad3-db31-a1be-7ff34efb0000?\_amp=true](https://www.haaretz.com/israel-news/2022-07-27/ty-article-magazine/.premium/crispr-technology-for-dna-editing-might-raise-cancer-risk-israeli-scientists-say/00000182-3ad3-db31-a1be-7ff34efb0000?_amp=true) [https://www.reddit.com/r/BCRX/comments/o9x38h/chill\_bcrx\_is\_just\_fine/h3t2t1w/?context=3](https://www.reddit.com/r/BCRX/comments/o9x38h/chill_bcrx_is_just_fine/h3t2t1w/?context=3) ​ [https://www.fda.gov/regulatory-information/search-fda-guidance-documents/long-term-follow-after-administration-human-gene-therapy-products](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/long-term-follow-after-administration-human-gene-therapy-products) ​ Just remember you were totally going to blindly accept dumb shit - no risk increases - prior to these sources...
BCRX!! But lemme explain(just a little), unlike everyone else here. Prior to 2020 basically we’re doing about 15M in sales, had their drug Orladeyo approved for HAE, and expect to do no less than $250M in revenue. Management (and myself) expects it to grow to $1B+ in sales per year. Massive growth. Phase 3 factor D treatment to treat PNH going right now. It was paused by the FDA, but the dose was lowered and thus far is still continuing. The phase one and safety data is exceptional, and the treatment is a pill instead of IV, and many have to get blood transfusions multiple times a week. That’s not necessary with our drug. It may be a ways out from approval (I’m thinking 2024 most likely), but that’s going to be 10 Orladeyos in one drug. This treatment can also be parlayed in to treating about 8 other rare diseases, so you can see the upside of the company which is currently valued at just $2.25B, trading around $13/share currently.
I have 737 shares of $BCRX I love biotech.
>\*U.S. Government Exercises Option to Purchase Additional RAPIVAB From BioCryst for Pandemic Influenza Preparedness $BCRX ^\*Walter ^Bloomberg ^[@DeItaone](http://twitter.com/DeItaone) ^at ^2022-08-25 ^07:09:16 ^EDT-0400
Good luck with that brother! Im currently leveraged in BCRX, SELB, SRRK, KPMH. Bought at today’s low. Fingers crossed 🤞🏼
Salute brother. BCRX Is such a fantastic long hold. I cant afford holding it but that would be my #1 plan if I could!
Congrats. I am holding BCRX long-term. Yesterday was good but still down a big amount there.
Main breakout target today: PLRX A classic high-tight flag. Made a very big move, price range contracted, and it consolidated long enough for the 10ma to catch up to the action. 10ma today combined with a breakout of about $20 will be signal for a buy. [https://i.imgur.com/2M6oF7r.png](https://i.imgur.com/2M6oF7r.png) Secondary targets: HRMY, BCRX
I've been watching many of these too. Been pretty disappointed with CHWY this week though. It's regressed pretty reliably every day it's up. I like BCRX the most here. I was probably early yesterday since it failed to stay above 12. Hoping for it to breakout soon.
Todays breakout watchlist: SIGA, CHWY, AGL, BCRX, ACET, BCYC, HRMY, KRYS, PLRX Side note: DXY has been following technical principles more cleanly than anything I've ever seen. Look at how closely it respects the moving averages, and even had a consolidation breakout. Currently sitting right on 20ma potential support. Anyway just found it interesting. [https://i.imgur.com/7YpQ5PH.png](https://i.imgur.com/7YpQ5PH.png)
Bought 8/19 12c on BCRX for the breakout
Not only do I hate myself for having AMC I wanna find the guy with the BCRX DD and kick him in his ballsack too
Hey the BCRX I listened to some asshole about is up today🤡
Top 5: HZNP, BCRX, IDYA, MRNA (just started this position last week), CRSP
I like BCRX but they’ve been having a rough time of it, im still confident in them long term. For food im just looking at the general indexes. Im a college kid and don’t have much money so im keeping it tight.
BCRX is a bio tech company that is on the verge of making several new drugs. This DD post got me started. I recently added alot to this position since it dipped on news that trials for one of their drugs needed to be investigated. DD post that got me interested: https://www.reddit.com/r/wallstreetbets/comments/mtzhp2/bcrx\_dd\_the\_embarrassment\_of\_riches/?sort=new
Ok, dont know market caps , apologies. Bird flu stocks... NNVC, BCRX, NVAX, AAVI, BCRX, CRXL, HEB, SVA, VICL...2005 BIRD FLU OUTBREAK ALL did well...
Agreed. I like BCRX. It's been beaten down lately. Could say the same for AMRN too. 600 million cash on hand. Trading at around a 1 billion mkt cap with a drug that has the potential to do 5 billion in sales. Already FDA approved.
Investing in Biotech is a wild ride so far only BCRX has been absolutely worth it (been holding at 3 average since the start of the pandemic) but your ticker looks interesting will keep an eye on!
Nvidia, Marvel and BCRX are carrying me for the year. Even through many other down plays, but most mine are 3-4 years out from hitting when I bought them.
You should check out $BCRX, upcoming bio pharmaceutical company
BCRX, new dip every couple weeks due to shorts then back up to 20. Been buying since $9.00
Days like this are a fucking dream. NIO 20C, DIDI 3C, IRNT 4C.....all printed. SOFI 10C, PLTR 13C, BCRX 17C all on the brink.
BCRX Last chance to get in under $20. Once it breaks $20 the Moon is the next stop.
#Ban Bet Lost /u/Beautiful_Ad_3053 (0/1) made a bet that BCRX would go to 20.0 when it was 18.3099 and it did not, so they were banned for a week.
BCRX $19 puts is the play this week boys let’s get this paper. Position 5 at cost of 200 per put exp 3/18
**Ban Bet Created:** **/u/Beautiful_Ad_3053** bet **BCRX** goes from **18.31** to **20.0** before **2022-03-01 09:28:19.764274-05:00**
Up on BCRX about $100K. Like that stock!
those fuckers were right on BCRX. congrats.
Anyone else on the BCRX train? Been carrying my portfolio the last 2 months.
I like BCRX in general, but they’re up 56% percent over the last few months (at all time highs now) and earnings is next Wednesday. Potential hard selloff between now and then I’d think.
Since it is now positions or BAN. BCRX is mooning! 300 Shares at $13.19.(I am going to lose 100 this Friday since I sold the $17 Covered Call) 2 1-23 $20 Calls 4 1-23 $30 Calls
$BCRX is killing it in the market today
BCRX. Had it at $2.50 ish, sold it at $5. It's now at $17.79...